Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis
TBC
Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Production of deoxycholic acid by low-abundant microbial species is associated with impaired glucose metabolism
GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota
The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
Synergy and oxygen adaptation for development of next-generation probiotics